Literature DB >> 23633657

Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography.

Julia M Wessel1, Folkert K Horn, Ralf P Tornow, Matthias Schmid, Christian Y Mardin, Friedrich E Kruse, Anselm G Juenemann, Robert Laemmer.   

Abstract

PURPOSE: To compare the longitudinal loss of RNFL thickness measurements by SD-OCT in healthy individuals and glaucoma patients with or without progression concerning optic disc morphology.
METHODS: A total of 62 eyes, comprising 38 glaucomatous eyes with open angle glaucoma and 24 healthy controls, were included in the study (Erlangen Glaucoma Registry, NTC00494923). All patients were investigated annually over a period of 3 years by Spectralis SD-OCT measuring peripapillary RNFL thickness. By masked comparative analysis of photographs, the eyes were classified into nonprogressive and progressive glaucoma cases. Longitudinal loss of RNFL thickness was compared with morphological changes of optic disc morphology.
RESULTS: Mixed model analysis of annual OCT scans revealed an estimated annual decrease of the RNFL thickness by 2.12 μm in glaucoma eyes with progression, whereas glaucoma eyes without progression in optic disc morphology lost 1.18 μm per year in RNFL thickness (P = 0.002). The rate of change in healthy eyes was 0.60 μm and thereby also significantly lower than in glaucoma eyes with progression (P < 0.001). The intrasession variability of three successive measurements without head repositioning was 1.5 ± 0.7 μm. The loss of mean RNFL thickness exceeded the intrasession variability in 60% of nonprogressive eyes, and in 85% of progressive eyes after 3 years.
CONCLUSIONS: LONGITUDINAL MEASUREMENTS OF RNFL THICKNESS USING SD-OCT SHOW A MORE PRONOUNCED REDUCTION OF RNFL THICKNESS IN PATIENTS WITH PROGRESSION COMPARED WITH PATIENTS WITHOUT PROGRESSION IN GLAUCOMATOUS OPTIC DISC CHANGES. (www.clinicaltrials.gov number, NTC00494923.).

Entities:  

Keywords:  glaucoma; optic disc morphology; optical coherence tomography; progression

Mesh:

Year:  2013        PMID: 23633657     DOI: 10.1167/iovs.12-9786

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  Optical Coherence Tomography and Glaucoma Progression: A Comparison of a Region of Interest Approach to Average Retinal Nerve Fiber Layer Thickness.

Authors:  Abinaya Thenappan; Carlos Gustavo De Moraes; Diane L Wang; Daiyan Xin; Ravivarn Jarukasetphon; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2017-05       Impact factor: 2.503

3.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

4.  Comparison of event-based analysis of glaucoma progression assessed subjectively on visual fields and retinal nerve fibre layer attenuation measured by optical coherence tomography.

Authors:  Sushmita Kaushik; Samyak Mulkutkar; Surinder Singh Pandav; Neelam Verma; Amod Gupta
Journal:  Int Ophthalmol       Date:  2014-12-13       Impact factor: 2.031

5.  Automatic and robust segmentation of endoscopic OCT images and optical staining.

Authors:  Jianlin Zhang; Wu Yuan; Wenxuan Liang; Shanyong Yu; Yanmei Liang; Zhiyong Xu; Yuxing Wei; Xingde Li
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

6.  Structural changes of macular inner retinal layers in early normal-tension and high-tension glaucoma by spectral-domain optical coherence tomography.

Authors:  Florian S M Edlinger; Laura M Schrems-Hoesl; Christian Y Mardin; Robert Laemmer; Friedrich E Kruse; Wolfgang A Schrems
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-09       Impact factor: 3.117

Review 7.  [Structural alterations during the course of glaucoma disease].

Authors:  C Y Mardin; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

8.  Glaucoma progression detection using nonlocal Markov random field prior.

Authors:  Akram Belghith; Christopher Bowd; Felipe A Medeiros; Madhusudhanan Balasubramanian; Robert N Weinreb; Linda M Zangwill
Journal:  J Med Imaging (Bellingham)       Date:  2014-12-29

9.  Glaucoma Structural and Functional Progression in American and Korean Cohorts.

Authors:  Tigran Kostanyan; Kyung Rim Sung; Joel S Schuman; Yun Ling; Katie A Lucy; Richard A Bilonick; Hiroshi Ishikawa; Larry Kagemann; Jin Y Lee; Gadi Wollstein
Journal:  Ophthalmology       Date:  2016-01-14       Impact factor: 12.079

Review 10.  Clinical characteristics and current treatment of glaucoma.

Authors:  Laura P Cohen; Louis R Pasquale
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.